Is the Goodman (ASX:GMG) share price overvalued?

Is the Goodman Group (ASX:GMG) share price overvalued or can it keep on climbing higher from here? Here's what these brokers think…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Goodman Group (ASX: GMG) share price is out of form on Wednesday.

In afternoon trade, the integrated property company's shares are down 1% to $19.32.

A woman with black afro hair and wearing a white t-shirt shrugs and purses her lips

Image source: Getty Images

Why is the Goodman share price dropping?

Today's weakness in the Goodman share price may have been driven by a broker note out of Goldman Sachs this morning.

According to the note, the broker has retained its sell rating but lifted its price target slightly to $13.31.

Based on the current Goodman share price, this implies potential downside of 31% for its shares over the next 12 months.

Why is Goldman bearish?

Goldman has been looking at the company's valuation and particularly its Funds Management operations.

It commented: "We estimate that GMG's current pricing values its Funds Management operations at 26% of its Mar-21 external AUM balance or 32x FY22E Management EBITDA. This compares to an average of 8% (or 20x FY22E fee-related EBITDA) for US-listed Alternative Asset Managers covered by GS. Relative to traditional fund managers and transactional evidence, GMG's valuation premium is even more pronounced."

And while the broker acknowledges that Logistics asset valuations remain strong, it still isn't enough for Goldman.

"Pricing of Logistics assets remains strong (as demonstrated by recent transactions in the Australian market in particular). However, we estimate that the weighted average cap rate of both GMG's AUM and its co-investments would need to tighten to just 2.5% (vs. 4.7% at Dec-20) in order for GMG's current pricing (as a % of AUM) to be in line with the average price paid for Australian RE Fund Management groups in M&A transactions since 2010," the broker said.

In light of this, it sees no reason to change its recommendations or valuation and has held firm with its sell rating.

Though, Goldman does admit that there is upside risk to its target price.

It explained: "Key upside risks to our TP and rating include: stronger investor demand for GMG-managed products than we allow for (impacting overall AUM growth rates); a more benign valuation decline than we assumed for Logistics assets globally; and stronger tenant demand for GMG's development book than we allow for (impacting development margins, the rate of AUM growth, and overall NOI growth rates)."

Is anyone bullish?

Goldman Sachs may be bearish on the Goodman share price, but not everybody is.

Earlier this month, analysts at Citi put a buy rating and $22.10 price target on the company's shares.

Based on the current Goodman share price, this implies potential upside of 14% over the next 12 months.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A happy family of four on holidays stand on a jetty and cheer.
Broker Notes

Down 40% in 2026, should you buy the big dip in Life360 shares?

A leading analyst offers his outlook for Life360 shares.

Read more »

Buy and sell on yellow paper with pins on them and several share price lines.
Broker Notes

Sell alert! Why this expert is calling time on Nuix and Brainchip shares

A leading analyst forecasts more pain to come for Brainchip and Nuix shares. But why?

Read more »

a man lies on his back on grass with his eyes shut and a contented look on his face as though he is dreaming
Broker Notes

With global populations ageing, are ResMed shares a good buy today?

A leading expert delivers his verdict on the outlook for ResMed shares.

Read more »

Focused man entrepreneur with glasses working, looking at laptop screen thinking about something intently while sitting in the office.
Broker Notes

Buy, hold, sell: Clarity Pharmaceuticals, New Hope, and Orica shares

Brokers have been looking at these shares this week. Are they bullish?

Read more »

Coal miner holding a giant coal rock in his hand and making a circle with his other hand.
Broker Notes

What is this broker saying about New Hope Group shares?

Here's Bell Potter's guidance following earnings results.

Read more »

A young woman wearing a red and white striped t-shirt puts her hand to her chin and looks sideways as she wonders whether to buy ASX shares
Broker Notes

3 ASX 200 shares at 52-week lows: Buy, hold, or sell?

These ASX 200 shares have experienced significant falls over the past 12 months. Is there value here?

Read more »

A man casually dressed looks to the side in a pensive, thoughtful manner with one hand under his chin, holding a mobile phone in his hand while thinking about something.
Broker Notes

Buy, hold, sell: BHP, CSL, and Woodside shares

Let's see if analysts are bullish or bearish on these giants.

Read more »